Pathologies involving the S100 proteins and rage

Subcellular Biochemistry

Volumn 45, Issue , 2007, Pages 93-138

  Heizmann, Claus W ^a   Ackermann, G E ^a   Galichet, A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Calcium; EF hand; Human diseases; RAGE; S100 proteins

Indexed keywords

ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; CALCIUM BINDING PROTEIN; CALGRANULIN A; CALGRANULIN B; CELL CYCLE PROTEIN; CHEMOTACTIC FACTOR; IMMUNOGLOBULIN RECEPTOR; LIPOCORTIN 2; PROTEIN S 100; S100 CALCIUM BINDING PROTEIN A10; S100A11 PROTEIN, HUMAN; S100A2 PROTEIN, HUMAN; S100A3 PROTEIN, HUMAN; S100A4 PROTEIN, MOUSE; S100A5 PROTEIN, HUMAN; S100A6 PROTEIN, HUMAN; S100A7 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL; CHEMISTRY; HUMAN; PHYSIOLOGY; PROTEIN MOTIF; REVIEW;

ANIMALS; ANNEXIN A2; CALCIUM-BINDING PROTEINS; CALGRANULIN A; CALGRANULIN B; CELL CYCLE PROTEINS; CHEMOTACTIC FACTORS; EF HAND MOTIFS; HUMANS; RECEPTORS, IMMUNOLOGIC; S100 PROTEINS;

EID: 38849180234     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-6191-2_5     Document Type: Article

References (294)

1. Ackermann GE, Marenholz I, Wolfer DP, Chan WY, Schäfer B, Erne P, Heizmann CW. 2006. S100A1-deficient male mice exhibit increased exploratory activity and reduced anxiety-related responses. Biochim Biophys Acta - Molecular Cell Research, in press.
2. Adhikari BB, Wang K. 2001. S100A1 modulates skeletal muscle contraction by desensitizing calcium activation of isometric tension, stiffness and ATPase. FEBS Lett 497(2, 3):95-98.
3. Ambartsumian N, Grigorian M, Lukanidin E. 2005. Genetically modified mouse models to study the role of metastasis-promoting S100A4(mts1) protein in metastatic mammary cancer. J Dairy Res 72 Spec No:27-33.
4. Arcuri C, Giambanco I, Bianchi R, Donato R. 2002. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles. Neuroscience 109(2):371-388.
5. Arnesano F, Banci L, Bertini I, Fantoni A, Tenori L, Viezzoli MS. 2005. Structural interplay between calcium(II) and copper(II) binding to S100A13 protein. Angew Chem Int Ed Engl 44(39):6341-6344.
6. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD. 2004. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279(7):5059-5065.
7. Arumugam T, Simeone DM, Van Golen K, Logsdon CD. 2005. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 11(15):5356-5364.
8. Barger SW, Wolchok SR, Van Eldik LJ. 1992. Disulfide-linked S100 beta dimers and signal transduction. Biochim Biophys Acta 1160(1):105-112.
9. Baudier J, Bergeret E, Bertacchi N, Weintraub H, Gagnon J, Garin J. 1995. Interactions of myogenic bHLH transcription factors with calcium-binding calmodulin and S100a (alpha alpha) proteins. Biochemistry 34(24):7834-7846.
10. Baudier J, Gerard D. 1986. Ions binding to S100 proteins. II. Conformational studies and calciuminduced conformational changes in S100 alpha alpha protein: the effect of acidic pH and calcium incubation on subunit exchange in S100a (alpha beta) protein. J Biol Chem 261(18):8204-8212.
11. Baudier J, Glasser N, Gerard D. 1986. Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca 2+ binding on S100b protein. J Biol Chem 261(18):8192-8203.
12. Baudier J, Mochly-Rosen D, Newton A, Lee SH, Koshland DE, Jr., Cole RD. 1987. Comparison of S100b protein with calmodulin: interactions with melittin and microtubule-associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase C. Biochemistry 26(10):2886-2893.
13. Bell K, Shokrian D, Potenzieri C, Whitaker-Azmitia PM. 2003. Harm avoidance, anxiety, and response to novelty in the adolescent S-100beta transgenic mouse: role of serotonin and relevance to Down syndrome. Neuropsychopharmacology 28(10):1810-1816.
14. Benfenati F, Ferrari R, Onofri F, Arcuri C, Giambanco I, Donato R. 2004. S100A1 codistributes with synapsin I in discrete brain areas and inhibits the F-actin-bundling activity of synapsin I. J Neurochem 89:1260-1270.
15. Bertini I, Carrano CJ, Luchinat C, Piccioli M, Poggi L. 2002. A 15N NMR mobility study on the dicalcium P43M calbindin D9k and its mono-La3+-substituted form. Biochemistry 41(16):5104-5111.
16. Bhattacharya S, Bunick CG, Chazin WJ. 2004. Target selectivity in EF-hand calcium binding proteins. Biochim Biophys Acta 1742(1-3):69-79.
17. Bhattacharya S, Large E, Heizmann CW, Hemmings B, Chazin WJ. 2003. Structure of the Ca 2+ /S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase. Biochemistry 42(49):14416-14426.
18. Bierhaus A, Haslbeck KM, Humpert PM, Liliensiek B, Dehmer T, Morcos M, Sayed AA, Andrassy M, Schiekofer S, Schneider JG, Schulz JB, Heuss D, Neundorfer B, Dierl S, Huber J, Tritschler H, Schmidt AM, Schwaninger M, Haering HU, Schleicher E, Kasper M, Stern DM, Arnold B, Nawroth PP. 2004. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest 114(12):1741-1751.
19. Boeshans KM, Wolf R, Voscopoulos C, Gillette W, Esposito D, Mueser TC, Yuspa SH, Ahvazi B. 2006. Purification, crystallization and preliminary X-ray diffraction of human S100A15. Acta Crystallograph Sect F Struct Biol Cryst Commun 62(Pt 5):467-470.
20. Boni R, Burg G, Doguoglu A, Ilg EC, Schafer BW, Muller B, Heizmann CW. 1997. Immunohistochemical localization of the Ca 2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol 137(1):39-43.
21. Boom A, Pochet R, Authelet M, Pradier L, Borghgraef P, Van Leuven F, Heizmann CW, Brion JP. 2004. Astrocytic calcium/zinc binding protein S100A6 over expression in Alzheimer's disease and in PS1/APP transgenic mice models. Biochim Biophys Acta 1742(1-3):161-168.
22. Brodersen DE, Etzerodt M, Madsen P, Celis JE, Thogersen HC, Nyborg J, Kjeldgaard M. 1998. EFhands at atomic resolution: the structure of human psoriasin (S100A7) solved by MAD phasing. Structure 6(4):477-489.
23. Brodersen DE, Nyborg J, Kjeldgaard M. 1999. Zinc-binding site of an S100 protein revealed. Two crystal structures of Ca 2+ -bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. Biochemistry 38(6):1695-1704.
24. Bucciarelli LG, Kaneko M, Ananthakrishnan R, Harja E, Lee LK, Hwang YC, Lerner S, Bakr S, Li Q, Lu Y, Song F, Qu W, Gomez T, Zou YS, Yan SF, Schmidt AM, Ramasamy R. 2006. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury. Circulation 113(9):1226-1234.
25. Bucciarelli LG, Wendt T, Rong L, Lalla E, Hofmann MA, Goova MT, Taguchi A, Yan SF, Yan SD, Stern DM, Schmidt AM. 2002. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 59(7):1117-1128.
26. Businaro R, Leone S, Fabrizi C, Sorci G, Donato R, Lauro GM, Fumagalli L. 2006. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J Neurosci Res 83(5):897-906.
27. Calabretta B, Battini R, Kaczmarek L, de Riel JK, Baserga R. 1986. Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. J Biol Chem 261(27):12628-12632.
28. Camby I, Lefranc F, Titeca G, Neuci S, Fastrez M, Dedecken L, Schafer BW, Brotchi J, Heizmann CW, Pochet R, Salmon I, Kiss R, Decaestecker C. 2000. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours. Neuropathol Appl Neurobiol 26(1):76-90.
29. Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, Terkeltaub R. 2005. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 175(12):8296-8302.
30. Chan WY, Xia CL, Dong DC, Heizmann CW, Yew DT. 2003. Differential expression of S100 proteins in the developing human hippocampus and temporal cortex. Microsc Res Tech 60(6):600-613.
31. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, Nawroth PP. 2003. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198(10): 1507-1515.
32. Choi KC, Leung PC, Jeung EB. 2005. Biology and physiology of Calbindin-D9k in female reproductive tissues: involvement of steroids and endocrine disruptors. Reprod Biol Endocrinol 3:66.
33. Chou DK, Zhang J, Smith FI, McCaffery P, Jungalwala FB. 2004. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration. J Neurochem 90(6): 1389-1401.
34. Cross SS, Hamdy FC, Deloulme JC, Rehman I. 2005. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46(3):256-269.
35. De Vriese AS, Tilton RG, Mortier S, Lameire NH. 2006. Myofibroblast transdifferentiation of mesothelial cells is mediated by rage and contributes to peritoneal fibrosis in uraemia. Nephrol Dial Transplant.
36. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B. 2003. RAGE mediates amyloidbeta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9(7): 907-913.
37. Deloulme JC, Gentil BJ, Baudier J. 2003. Monitoring of S100 homodimerization and heterodimeric interactions by the yeast two-hybrid system. Microsc Res Tech 60(6):560-568.
38. Delphin C, Ronjat M, Deloulme JC, Garin G, Debussche L, Higashimoto Y, Sakaguchi K, Baudier J. 1999. Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53. J Biol Chem 274(15):10539-10544.
39. Dempsey AC, Walsh MP, Shaw GS. 2003. Unmasking the annexin I interaction from the structure of Apo-S100A11. Structure 11(7):887-897.
40. Ding Q, Keller JN. 2005a. Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim Biophys Acta 1746(1):18-27.
41. Ding Q, Keller JN. 2005b. Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain. Neurosci Lett 373(1):67-72.
42. Donato R. 1988. Calcium-independent, pH-regulated effects of S-100 proteins on assembly-disassembly of brain microtubule protein in vitro. J Biol Chem 263(1):106-110.
43. Donato R. 1991. Perspectives in S-100 protein biology. Review article. Cell Calcium 12(10):713-726.
44. Donato R. 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33(7):637-668.
45. Donato R. 2003. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60(6):540-551.
46. Donato R, Giambanco I, Aisa MC, di Geronimo G, Ceccarelli P, Rambotti MG, Spreca A. 1989. Cardiac S-100a0 protein: purification by a simple procedure and related immunocytochemical and immunochemical studies. Cell Calcium 10(2):81-92.
47. Donier E, Rugiero F, Okuse K, Wood JN. 2005. Annexin II light chain p11 promotes functional expression of acid-sensing ion channel ASIC1a. J Biol Chem 280(46):38666-38672.
48. Drohat AC, Baldisseri DM, Rustandi RR, Weber DJ. 1998. Solution structure of calcium-bound rat S100B(betabeta) as determined by nuclear magnetic resonance spectroscopy. Biochemistry 37(9):2729-2740.
49. Drohat AC, Tjandra N, Baldisseri DM, Weber DJ. 1999. The use of dipolar couplings for determining the solution structure of rat apo-S100B(betabeta). Protein Sci 8(4):800-809.
50. Du XJ, Cole TJ, Tenis N, Gao XM, Kontgen F, Kemp BE, Heierhorst J. 2002. Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol Cell Biol 22(8): 2821-2829.
51. Du Yan S, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte WW, Rajavashisth T, Chen X, Godman GC, Stern D, Schmidt AM. 1997. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad SciUSA94(10):5296-5301.
52. Dyck RH, Bogoch, II, Marks A, Melvin NR, Teskey GC. 2002. Enhanced epileptogenesis in S100B knockout mice. Brain Res Mol Brain Res 106(1, 2):22-29.
53. El-Naaman C, Grum-Schwensen B, Mansouri A, Grigorian M, Santoni-Rugiu E, Hansen T, Kriajevska M, Schafer BW, Heizmann CW, Lukanidin E, Ambartsumian N. 2004. Cancer predisposition in mice deficient for the metastasis-associated Mts1(S100A4) gene. Oncogene 23(20):3670-3680.
54. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K. 2004. S100 proteins in the epidermis. J Invest Dermatol 123(1):23-33.
55. Eckert RL, Lee KC. 2006. S100A7 (Psoriasin): a story of mice and men. J Invest Dermatol 126(7): 1442-1444.
56. Ehlermann P, Eggers K, Bierhaus A, Most P, Weichenhan D, Greten J, Nawroth PP, Katus HA, Remppis A. 2006. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc Diabetol 5:6.
57. Ehlermann P, Remppis A, Guddat O, Weimann J, Schnabel PA, Motsch J, Heizmann CW, Katus HA. 2000. Right ventricular upregulation of the Ca(2+) binding protein S100A1 in chronic pulmonary hypertension. Biochim Biophys Acta 1500(2):249-255.
58. Emberley ED, Murphy LC, Watson PH. 2004. S100A7 and the progression of breast cancer. Breast Cancer Res 6(4):153-159.
59. Endo H, Takenaga K, Kanno T, Satoh H, Mori S. 2002. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. J Biol Chem 277(29):26396-26402.
60. Eue I, Sorg C. 2001. Arachidonic acid specifically regulates binding of S100A8/9, a heterodimer complex of the S100 class of calcium binding proteins, to human microvascular endothelial cells. Atherosclerosis 154(2):505-508.
61. Fano G, Angelella P, Mariggio D, Aisa MC, Giambanco I, Donato R. 1989a. S-100a0 protein stimulates the basal (Mg2+-activated) adenylate cyclase activity associated with skeletal muscle membranes. FEBS Lett 248(1-2):9-12.
62. Fano G, Marsili V, Angelella P, Aisa MC, Giambanco I, Donato R. 1989b. S-100a0 protein stimulates Ca 2+ -induced Ca 2+ release from isolated sarcoplasmic reticulum vesicles. FEBS Lett 255(2):381-384.
63. Farnaes L, Ditzel HJ. 2003. Dissecting the cellular functions of annexin XI using recombinant human annexin XI-specific autoantibodies cloned by phage display. J Biol Chem 278(35):33120-33126.
64. Fernandez-Fernandez MR, Veprintsev DB, Fersht AR. 2005. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad SciUSA102(13):4735-4740.
65. Ferrari S, Calabretta B, deRiel JK, Battini R, Ghezzo F, Lauret E, Griffin C, Emanuel BS, Gurrieri F, Baserga R. 1987. Structural and functional analysis of a growth-regulated gene, the human calcyclin. J Biol Chem 262(17):8325-8332.
66. Filipek A, Heizmann CW, Kuznicki J. 1990. Calcyclin is a calcium and zinc binding protein. FEBS Lett 264(2):263-266.
67. Filipek A, Jastrzebska B, Nowotny M, Kuznicki J. 2002a. CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J Biol Chem 277(32):28848-28852.
68. Filipek A, Jastrzebska B, Nowotny M, Kwiatkowska K, Hetman M, Surmacz L, Wyroba E, Kuznicki J. 2002b. Ca2+ -dependent translocation of the calcyclin-binding protein in neurons and neuroblastoma NB-2a cells. J Biol Chem 277(23):21103-21109.
69. Flyvbjerg A, Denner L, Schrijvers BF, Tilton RG, Mogensen TH, Paludan SR, Rasch R. 2004. Longterm renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes 53(1): 166-172.
70. Franz C, Durussel I, Cox JA, Schafer BW, Heizmann CW. 1998. Binding of Ca 2+ and Zn2+ to human nuclear S100A2 and mutant proteins. J Biol Chem 273(30):18826-18834.
71. Fritz G, Heizmann CW, Kroneck PM. 1998. Probing the structure of the human Ca 2+ - and Zn2+-binding protein S100A3: spectroscopic investigations of its transition metal ion complexes, and three-dimensional structural model. Biochim Biophys Acta 1448(2):264-276.
72. Fritz G, Heizmann CW. 2004. 3D-structures of the Ca 2+ - and Zn2+-binding S100 proteins. A. Messerschmidt WB, M. Cygler, eds., editor. Chichester: John Wiley & Sons. p. 529-540.
73. Fritz G, Mittl PR, Vasak M, Grutter MG, Heizmann CW. 2002. The crystal structure of metal-free human EF-hand protein S100A3 at 1.7-A resolution. J Biol Chem 277(36):33092-33098.
74. Gerlai R, Roder J. 1996. Spatial and nonspatial learning in mice: effects of S100 beta overexpression and age. Neurobiol Learn Mem 66(2):143-154.
75. Gerlai R, Wojtowicz JM, Marks A, Roder J. 1995. Overexpression of a calcium-binding protein, S100 beta, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice. Learn Mem 2(1):26-39.
76. Geroldi D, Falcone C, Emanuele E. 2006. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr Med Chem 13(17):1971-1978.
77. Glenney JR, Jr., Kindy MS, Zokas L. 1989. Isolation of a new member of the S100 protein family: amino acid sequence, tissue, and subcellular distribution. J Cell Biol 108(2):569-578.
78. Goch G, Vdovenko S, Kozlowska H, Bierzynski A. 2005. Affinity of S100A1 protein for calcium increases dramatically upon glutathionylation. Febs J 272(10):2557-2565.
79. Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, Nowygrod S, Wolf BM, Caliste X, Yan SF, Stern DM, Schmidt AM. 2001. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159(2):513-525.
80. Gribenko AV, Hopper JE, Makhatadze GI. 2001. Molecular characterization and tissue distribution of a novel member of the S100 family of EF-hand proteins. Biochemistry 40(51):15538-15548.
81. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, 3rd, Araoz C. 1989. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad SciUSA86(19):7611-7615.
82. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G, Lukanidin E. 2001. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276(25):22699-22708.
83. Guignard F, Mauel J, Markert M. 1995. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J 309 (Pt 2):395-401.
84. Hagens G, Masouye I, Augsburger E, Hotz R, Saurat JH, Siegenthaler G. 1999. Calcium-binding protein S100A7 and epidermal-type fatty acid-binding protein are associated in the cytosol of human keratinocytes. Biochem J 339 (Pt 2):419-427.
85. Haimoto H, Kato K. 1987. S100a0 (alpha alpha) protein, a calcium-binding protein, is localized in the slow-twitch muscle fiber. J Neurochem 48(3):917-923.
86. Haimoto H, Kato K. 1988. S100a0 (alpha alpha) protein in cardiac muscle. Isolation from human cardiac muscle and ultrastructural localization. Eur J Biochem 171(1-2):409-415.
87. Hancq S, Salmon I, Brotchi J, De Witte O, Gabius HJ, Heizmann CW, Kiss R, Decaestecker C. 2004a. S100A5: a marker of recurrence in WHO grade I meningiomas. Neuropathol Appl Neurobiol 30(2):178-187.
88. Hancq S, Salmon I, Brotchi J, Gabius HJ, Heizmann CW, Kiss R, Decaestecker C. 2004b. Detection of S100B, S100A6 and galectin-3 ligands in meningiomas as markers of aggressiveness. Int J Oncol 25(5):1233-1240.
89. Hanford LE, Enghild JJ, Valnickova Z, Petersen SV, Schaefer LM, Schaefer TM, Reinhart TA, Oury TD. 2004. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 279(48):50019-50024.
90. Hatakeyama T, Okada M, Shimamoto S, Kubota Y, Kobayashi R. 2004. Identification of intracellular target proteins of the calcium-signaling protein S100A12. Eur J Biochem 271(18):3765-3775.
91. He CJ, Zheng F, Stitt A, Striker L, Hattori M, Vlassara H. 2000. Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease. Kidney Int 58(5):1931-1940.
92. Heierhorst J, Kobe B, Feil SC, Parker MW, Benian GM, Weiss KR, Kemp BE. 1996. Ca 2+ /S100 regulation of giant protein kinases. Nature 380(6575):636-639.
93. Heizmann CW. 2005. The importance of calcium-binding proteins in childhood diseases. J Pediatr 147(6):731-738.
94. Heizmann CW, Cox JA. 1998. New perspectives on S100 proteins: a multi-functional Ca 2+-, Zn(2+)-and Cu(2+)-binding protein family. Biometals 11(4):383-397.
95. Heizmann CW, Fritz G, Schafer BW. 2002. S100 proteins: structure, functions and pathology. Front Biosci 7:d1356-1368.
96. Heizmann CW, Schäfer BW, Fritz G. 2003. The familiy of S100 cell signaling proteins. In: Bradshaw RA, Dennis E, editors. Handbook of Cell Signaling. USA: Elsevier Science. p 87-93.
97. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. 2005. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92(11):1955-1958.
98. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. 2006. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312(2):184-197.
99. Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, Mayer D. 2005. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 11(14):5146-5152.
100. Hibi K, Fujitake S, Takase T, Kodera Y, Ito K, Akiyama S, Shirane M, Nakao A. 2003. Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway. Clin Cancer Res 9(11): 4282-4285.
101. Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, Henderson R, Robinson MJ, Hogg N. 2003. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 23(7): 2564-2576.
102. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97(7):889-901.
103. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutations in human cancers. Science 253(5015):49-53.
104. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, et al. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270(43):25752-25761.
105. Hoyaux D, Boom A, Van den Bosch L, Belot N, Martin JJ, Heizmann CW, Kiss R, Pochet R. 2002. S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients. J Neuropathol Exp Neurol 61(8):736-744.
106. Hsieh HL, Schafer BW, Cox JA, Heizmann CW. 2002. S100A13 and S100A6 exhibit distinct translocation pathways in endothelial cells. J Cell Sci 115(Pt 15):3149-3158.
107. Huber M, Siegenthaler G, Mirancea N, Marenholz I, Nizetic D, Breitkreutz D, Mischke D, Hohl D. 2005. Isolation and characterization of human repetin, a member of the fused gene family of the epidermal differentiation complex. J Invest Dermatol 124(5):998-1007.
108. Huttunen HJ, Fages C, Rauvala H. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274(28):19919-19924.
109. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H. 2000. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275(51):40096-40105.
110. Ikura M, Ames JB. 2006. Genetic polymorphism and protein conformational plasticity in the calmodulin superfamily: two ways to promote multifunctionality. Proc Natl Acad SciUSA103(5):1159-1164.
111. Ilg EC, Troxler H, Burgisser DM, Kuster T, Markert M, Guignard F, Hunziker P, Birchler N, Heizmann CW. 1996. Amino acid sequence determination of human S100A12 (P6, calgranulin C, CGRP, CAAF1) by tandem mass spectrometry. Biochem Biophys Res Commun 225(1):146-150.
112. Inman KG, Yang R, Rustandi RR, Miller KE, Baldisseri DM, Weber DJ. 2002. Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12. J Mol Biol 324(5):1003-1014.
113. Ishikawa K, Nakagawa A, Tanaka I, Suzuki M, Nishihira J. 2000. The structure of human MRP8, a member of the S100 calcium-binding protein family, by MAD phasing at 1.9 A resolution. Acta Crystallogr D Biol Crystallogr 56(Pt 5):559-566.
114. Isobe T, Ishioka N, Masuda T, Takahashi Y, Ganno S, Okuyama T. 1983. A rapid separation of S100 subunits by high performance liquid chromatography: the subunit compositions of S100 proteins. Biochem Int 6(3):419-426.
115. Itou H, Yao M, Fujita I, Watanabe N, Suzuki M, Nishihira J, Tanaka I. 2002. The crystal structure of human MRP14 (S100A9), a Ca(2+)-dependent regulator protein in inflammatory process. J Mol Biol 316(2):265-276.
116. Jenkinson SR, Barraclough R, West CR, Rudland PS. 2004. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br J Cancer 90(1):253-262.
117. Jensen LJ, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A. 2006. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. J Endocrinol 188(3): 493-501.
118. Julenius K, Robblee J, Thulin E, Finn BE, Fairman R, Linse S. 2002. Coupling of ligand binding and dimerization of helix-loop-helix peptides: spectroscopic and sedimentation analyses of calbindin D9k EF-hands. Proteins 47(3):323-333.
119. Kane D, Roth J, Frosch M, Vogl T, Bresnihan B, FitzGerald O. 2003. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis Rheum 48(6): 1676-1685.
120. Kato K, Kimura S. 1985. S100ao (alpha alpha) protein is mainly located in the heart and striated muscles. Biochim Biophys Acta 842(2-3):146-150.
121. Kerkhoff C, Klempt M, Kaever V, Sorg C. 1999. The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J Biol Chem 274(46):32672-32679.
122. Kerkhoff C, Sorg C, Tandon NN, Nacken W. 2001. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 40(1):241-248.
123. Kettlewell S, Most P, Currie S, Koch WJ, Smith GL. 2005. S100A1 increases the gain of excitationcontraction coupling in isolated rabbit ventricular cardiomyocytes. J Mol Cell Cardiol 39(6):900-910.
124. Kiewitz R, Acklin C, Minder E, Huber PR, Schafer BW, Heizmann CW. 2000a. S100A1, a new marker for acute myocardial ischemia. Biochem Biophys Res Commun 274(3):865-871.
125. Kiewitz R, Acklin C, Schafer BW, Maco B, Uhrik B, Wuytack F, Erne P, Heizmann CW. 2003. Ca 2+ -dependent interaction of S100A1 with the sarcoplasmic reticulum Ca 2+ -ATPase2a and phospholamban in the human heart. Biochem Biophys Res Commun 306(2):550-557.
126. Kiewitz R, Lyons GE, Schafer BW, Heizmann CW. 2000b. Transcriptional regulation of S100A1 and expression during mouse heart development. Biochim Biophys Acta 1498(2-3):207-219.
127. Kilby PM, Van Eldik LJ, Roberts GC. 1996. The solution structure of the bovine S100B protein dimer in the calcium-free state. Structure 4(9):1041-1052.
128. Kiryushko D, Novitskaya V, Soroka V, Klingelhofer J, Lukanidin E, Berezin V, Bock E. 2006. Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein. Mol Cell Biol 26(9): 3625-3638.
129. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM. 1999. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274(44):31740-31749.
130. Kizawa K, Troxler H, Kleinert P, Inoue T, Toyoda M, Morohashi M, Heizmann CW. 2002. Characterization of the cysteine-rich calcium-binding S100A3 protein from human hair cuticles. Biochem Biophys Res Commun 299(5):857-862.
131. Kizawa K, Tsuchimoto S, Hashimoto K, Uchiwa H. 1998. Gene expression of mouse S100A3, a cysteine-rich calcium-binding protein, in developing hair follicle. J Invest Dermatol 111(5): 879-886.
132. Koltzscher M, Neumann C, Konig S, Gerke V. 2003. Ca 2+ -dependent binding and activation of dormant ezrin by dimeric S100P. Mol Biol Cell 14(6):2372-2384.
133. Kriajevska M, Fischer-Larsen M, Moertz E, Vorm O, Tulchinsky E, Grigorian M, Ambartsumian N, Lukanidin E. 2002. Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphataseinteracting proteins, is a new target for the metastasis-associated protein S100A4 (Mts1). J Biol Chem 277(7):5229-5235.
134. Kulski JK, Lim CP, Dunn DS, Bellgard M. 2003. Genomic and phylogenetic analysis of the S100A7 (Psoriasin) gene duplications within the region of the S100 gene cluster on human chromosome 1q21. J Mol Evol 56(4):397-406.
135. Kuznicki J, Filipek A, Heimann P, Kaczmarek L, Kaminska B. 1989a. Tissue specific distribution of calcyclin-10.5 kDa Ca 2+ -binding protein. FEBS Lett 254(1-2):141-144.
136. Kuznicki J, Filipek A, Hunziker PE, Huber S, Heizmann CW. 1989b. Calcium-binding protein from mouse Ehrlich ascites-tumour cells is homologous to human calcyclin. Biochem J 263(3):951-956.
137. Kwon M, Yoon CS, Jeong W, Rhee SG, Waisman DM. 2005. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin. J Biol Chem 280(25):23584-23592.
138. Lee SW, Tomasetto C, Sager R. 1991. Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad SciUSA88(7):2825-2829.
139. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R. 1992. Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad SciUSA89(6):2504-2508.
140. Lee YT, Jacob J, Michowski W, Nowotny M, Kuznicki J, Chazin WJ. 2004. Human Sgt1 binds HSP90 through the CHORD-Sgt1 domain and not the tetratricopeptide repeat domain. J Biol Chem 279(16):16511-16517.
141. Leukert N, Vogl T, Strupat K, Reichelt R, Sorg C, Roth J. 2006. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity. J Mol Biol 359(4):961-972.
142. Li J, Schmidt AM. 1997. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272(26):16498-16506.
143. Li ZH, Bresnick AR. 2006. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res 66(10):5173-5180.
144. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, Plachky J, Grone HJ, Kurschus FC, Schmidt AM, Yan SD, Martin E, Schleicher E, Stern DM, Hammerling GG, Nawroth PP, Arnold B. 2004. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113(11):1641-1650.
145. Lu C, He JC, Cai W, Liu H, Zhu L, Vlassara H. 2004. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci U S A 101(32):11767-11772.
146. Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD. 2001. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol 171(1):29-45.
147. Luu HH, Zhou L, Haydon RC, Deyrup AT, Montag AG, Huo D, Heck R, Heizmann CW, Peabody TD, Simon MA, He TC. 2005. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett 229(1):135-148.
148. Maco B, Mandinova A, Durrenberger MB, Schafer BW, Uhrik B, Heizmann CW. 2001. Ultrastructural distribution of the S100A1 Ca 2+ -binding protein in the human heart. Physiol Res 50(6):567-574.
149. Madsen P, Rasmussen HH, Leffers H, Honore B, Celis JE. 1992. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J Invest Dermatol 99(3):299-305.
150. Madsen P, Rasmussen HH, Leffers H, Honore B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, et al. 1991. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 97(4):701-712.
151. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. 1997. Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 74(4):464-469.
152. Mandinova A, Soldi R, Graziani I, Bagala C, Bellum S, Landriscina M, Tarantini F, Prudovsky I, Maciag T. 2003. S100A13 mediates the copper-dependent stress-induced release of IL-1alpha from both human U937 and murine NIH 3T3 cells. J Cell Sci 116(Pt 13):2687-2696.
153. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, Frings W, Schonlau F, Roth J, Sorg C, Nacken W. 2003. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol 23(3):1034-1043.
154. Mannan AU, Nica G, Nayernia K, Mueller C, Engel W. 2003. Calgizarrin like gene (Cal) deficient mice undergo normal spermatogenesis. Mol Reprod Dev 66(4):431-438.
155. Marenholz I, Heizmann CW. 2004. S100A16, a ubiquitously expressed EF-hand protein which is upregulated in tumors. Biochem Biophys Res Commun 313(2):237-244.
156. Marenholz I, Heizmann CW, Fritz G. 2004a. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322(4):1111-1122.
157. Marenholz I, Heizmann CW, Fritz G. 2004b. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322(4):1111-1122.
158. Marenholz I, Lovering RC, Heizmann CW. 2006. An update of the S100 nomenclature. Biochim Biophys Acta - Molecular Cell Research, in press.
159. Marenholz I, Zirra M, Fischer DF, Backendorf C, Ziegler A, Mischke D. 2001. Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library. Genome Res 11(3):341-355.
160. Marsili V, Mancinelli L, Menchetti G, Fulle S, Baldoni F, Fano G. 1992. S-100ab increases Ca2+ release in purified sarcoplasmic reticulum vesicles of frog skeletal muscle. J Muscle Res Cell Motil 13(5):511-515.
161. Matsuzawa SI, Reed JC. 2001. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7(5):915-926.
162. McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RS, Geczy CL. 2005. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem 280(50):41521-41529.
163. Menke M, Ross M, Gerke V, Steinem C. 2004. The molecular arrangement of membrane-bound annexin A2-S100A10 tetramer as revealed by scanning force microscopy. Chembiochem 5(7):1003-1006.
164. Mikkelsen SE, Novitskaya V, Kriajevska M, Berezin V, Bock E, Norrild B, Lukanidin E. 2001. S100A12 protein is a strong inducer of neurite outgrowth from primary hippocampal neurons. J Neurochem 79(4):767-776.
165. Minami H, Tokumitsu H, Mizutani A, Watanabe Y, Watanabe M, Hidaka H. 1992. Specific binding of CAP-50 to calcyclin. FEBS Lett 305(3):217-219.
166. Miwa N, Kawamura S. 2003. Frog p26olf, a molecule with two S100-like regions in a single peptide. Microsc Res Tech 60(6):593-599.
167. Moll UM, LaQuaglia M, Benard J, Riou G. 1995. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci U S A 92(10):4407-4411.
168. Moroz OV, Antson AA, Dodson EJ, Burrell HJ, Grist SJ, Lloyd RM, Maitland NJ, Dodson GG, Wilson KS, Lukanidin E, Bronstein IB. 2002. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr D Biol Crystallogr 58(Pt 3):407-413.
169. Moroz OV, Antson AA, Grist SJ, Maitland NJ, Dodson GG, Wilson KS, Lukanidin E, Bronstein IB. 2003a. Structure of the human S100A12-copper complex: implications for host-parasite defence. Acta Crystallogr D Biol Crystallogr 59(Pt 5):859-867.
170. Moroz OV, Dodson GG, Wilson KS, Lukanidin E, Bronstein IB. 2003b. Multiple structural states of S100A12: A key to its functional diversity. Microsc Res Tech 60(6):581-592.
171. Most P, Bernotat J, Ehlermann P, Pleger ST, Reppel M, Borries M, Niroomand F, Pieske B, Janssen PM, Eschenhagen T, Karczewski P, Smith GL, Koch WJ, Katus HA, Remppis A. 2001. S100A1: a regulator of myocardial contractility. Proc Natl Acad SciUSA98(24):13889-13894.
172. Most P, Boerries M, Eicher C, Schweda C, Ehlermann P, Pleger ST, Loeffler E, Koch WJ, Katus HA, Schoenenberger CA, Remppis A. 2003a. Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2). J Biol Chem 278(48):48404-48412.
173. Most P, Boerries M, Eicher C, Schweda C, Volkers M, Wedel T, Sollner S, Katus HA, Remppis A, Aebi U, Koch WJ, Schoenenberger CA. 2005. Distinct subcellular location of the Ca 2+-binding protein S100A1 differentially modulates Ca 2+ -cycling in ventricular rat cardiomyocytes. J Cell Sci 118(Pt 2):421-431.
174. Most P, Pleger ST, Völkers M, Heidt B, Boerries M, Weichenhan D, Löffler E, Janssen PML, Eckhart AD, Martini J, Williams ML, Katus HA, Remppis A, Koch WJ. 2004. Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest 114(11):1550-1563.
175. Most P, Remppis A, Pleger ST, Loffler E, Ehlermann P, Bernotat J, Kleuss C, Heierhorst J, Ruiz P, Witt H, Karczewski P, Mao L, Rockman HA, Duncan SJ, Katus HA, Koch WJ. 2003b. Transgenic overexpression of the Ca 2+ -binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem 278(36):33809-33817.
176. Most P, Remppis A, Weber C, Bernotat J, Ehlermann P, Pleger ST, Kirsch W, Weber M, Uttenweiler D, Smith GL, Katus HA, Fink RH. 2003c. The C terminus (amino acids 75-94) and the linker region (amino acids 42-54) of the Ca 2+ -binding protein S100A1 differentially enhance sarcoplasmic Ca 2+ release in murine skinned skeletal muscle fibers. J Biol Chem 278(29):26356-26364.
177. Mueller A, Schafer BW, Ferrari S, Weibel M, Makek M, Hochli M, Heizmann CW. 2005. The calcium binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem.
178. Murphy LC, Murphy LJ, Tsuyuki D, Duckworth ML, Shiu RP. 1988. Cloning and characterization of a cDNA encoding a highly conserved, putative calcium binding protein, identified by an anti-prolactin receptor antiserum. J Biol Chem 263(5):2397-2401.
179. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267(21):14998-15004.
180. Nelson MR, Thulin E, Fagan PA, Forsen S, Chazin WJ. 2002. The EF-hand domain: a globally cooperative structural unit. Protein Sci 11(2):198-205.
181. Nishikawa T, Lee IS, Shiraishi N, Ishikawa T, Ohta Y, Nishikimi M. 1997. Identification of S100b protein as copper-binding protein and its suppression of copper-induced cell damage. J Biol Chem 272(37):23037-23041.
182. Nishiyama H, Knopfel T, Endo S, Itohara S. 2002. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc Natl Acad SciUSA99(6):4037-4042.
183. Novitskaya V, Grigorian M, Kriajevska M, Tarabykina S, Bronstein I, Berezin V, Bock E, Lukanidin E. 2000. Oligomeric forms of the metastasis-related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem 275(52):41278-41286.
184. Oram S, Cai X, Haleem R, Cyriac J, Wang Z. 2006. Regulation of calcium homeostasis by S100RVP, an androgen-regulated S100 protein in the rat ventral prostate. Prostate 66(7):768-778.
185. Ostendorp T, Heizmann CW, Kroneck PM, Fritz G. 2005. Purification, crystallization and preliminary X-ray diffraction studies on human Ca 2+ -binding protein S100B. Acta Crystallograph Sect F Struct Biol Cryst Commun 61(Pt 7):673-675.
186. Otterbein LR, Kordowska J, Witte-Hoffmann C, Wang CL, Dominguez R. 2002. Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution. Structure 10(4):557-567.
187. Oyama Y, Shishibori T, Yamashita K, Naya T, Nakagiri S, Maeta H, Kobayashi R. 1997. Two distinct anti-allergic drugs, amlexanox and cromolyn, bind to the same kinds of calcium binding proteins, except calmodulin, in bovine lung extract. Biochem Biophys Res Commun 240(2):341-347.
188. Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR. 2006. Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res 82(5):807-815.
189. Pan J, Rintala-Dempsey AC, Li Y, Shaw GS, Konermann L. 2006. Folding kinetics of the S100A11 protein dimer studied by time-resolved electrospray mass spectrometry and pulsed hydrogen-deuterium exchange. Biochemistry 45(9):3005-3013.
190. Paresce DM, Ghosh RN, Maxfield FR. 1996. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17(3):553-565.
191. Passey RJ, Williams E, Lichanska AM, Wells C, Hu S, Geczy CL, Little MH, Hume DA. 1999. A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. J Immunol 163(4):2209-2216.
192. Pedersen MV, Kohler LB, Grigorian M, Novitskaya V, Bock E, Lukanidin E, Berezin V. 2004. The Mts1/S100A4 protein is a neuroprotectant. J Neurosci Res 77(6):777-786.
193. Pedrocchi M, Schafer BW, Mueller H, Eppenberger U, Heizmann CW. 1994. Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int J Cancer 57(5):684-690.
194. Pietas A, Schluns K, Marenholz I, Schafer BW, Heizmann CW, Petersen I. 2002. Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics 79(4):513-522.
195. Pleger ST, Remppis A, Heidt B, Volkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Muller OJ, Eckhart AD, Katus HA, Koch WJ, Most P. 2005. S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther 12(6):1120-1129.
196. Potts BC, Smith J, Akke M, Macke TJ, Okazaki K, Hidaka H, Case DA, Chazin WJ. 1995. The structure of calcyclin reveals a novel homodimeric fold for S100 Ca(2+)-binding proteins. Nat Struct Biol 2(9):790-796.
197. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. 2005. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15(7):16R-28R.
198. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. 1997. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 272(14):9496-9502.
199. Raybaud-Diogene H, Tetu B, Morency R, Fortin A, Monteil RA. 1996. p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol 32B(3):143-149.
200. Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, Natarajan R. 2006a. Key role of SRC kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem.
201. Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L, Natarajan R. 2006b. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 281(19):13685-13693.
202. Remppis A, Greten T, Schafer BW, Hunziker P, Erne P, Katus HA, Heizmann CW. 1996. Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta 1313(3):253-257.
203. Remppis A, Most P, Loffler E, Ehlermann P, Bernotat J, Pleger S, Borries M, Reppel M, Fischer J, Koch WJ, Smith G, Katus HA. 2002. The small EF-hand Ca 2+ binding protein S100A1 increases contractility and Ca 2+ cycling in rat cardiac myocytes. Basic Res Cardiol 97 Suppl 1:I56-62.
204. Remppis A, Pleger ST, Most P, Lindenkamp J, Ehlermann P, Schweda C, Loffler E, Weichenhan D, Zimmermann W, Eschenhagen T, Koch WJ, Katus HA. 2004. S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts. J Gene Med 6(4):387-394.
205. Reppel M, Sasse P, Piekorz R, Tang M, Roell W, Duan Y, Kletke A, Hescheler J, Nurnberg B, Fleischmann BK. 2005. S100A1 enhances the L-type Ca 2+ current in embryonic mouse and neonatal rat ventricular cardiomyocytes. J Biol Chem 280(43):36019-36028.
206. Rety S, Osterloh D, Arie JP, Tabaries S, Seeman J, Russo-Marie F, Gerke V, Lewit-Bentley A. 2000. Structural basis of the Ca(2+)-dependent association between S100C (S100A11) and its target, the N-terminal part of annexin I. Structure 8(2):175-184.
207. Rety S, Sopkova J, Renouard M, Osterloh D, Gerke V, Tabaries S, Russo-Marie F, Lewit-Bentley A. 1999. The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat Struct Biol 6(1):89-95.
208. Ridinger K, Ilg EC, Niggli FK, Heizmann CW, Schafer BW. 1998. Clustered organization of S100 genes in human and mouse. Biochim Biophys Acta 1448(2):254-263.
209. Ridinger K, Schafer BW, Durussel I, Cox JA, Heizmann CW. 2000. S100A13. Biochemical characterization and subcellular localization in different cell lines. J Biol Chem 275(12):8686-8694.
210. Riuzzi F, Sorci G, Donato R. 2006. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J Biol Chem 281(12):8242-8253.
211. Robinson MJ, Tessier P, Poulsom R, Hogg N. 2002. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 277(5):3658-3665.
212. Rong LL, Trojaborg W, Qu W, Kostov K, Yan SD, Gooch C, Szabolcs M, Hays AP, Schmidt AM. 2004a. Antagonism of RAGE suppresses peripheral nerve regeneration. Faseb J 18(15):1812-1817.
213. Rong LL, Yan SF, Wendt T, Hans D, Pachydaki S, Bucciarelli LG, Adebayo A, Qu W, Lu Y, Kostov K, Lalla E, Yan SD, Gooch C, Szabolcs M, Trojaborg W, Hays AP, Schmidt AM. 2004b. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. Faseb J 18(15):1818-1825.
214. Roth J, Vogl T, Sorg C, Sunderkotter C. 2003. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 24(4):155-158.
215. Rothermundt M, Peters M, Prehn JH, Arolt V. 2003. S100B in brain damage and neurodegeneration. Microsc Res Tech 60(6):614-632.
216. Ruse M, Broome AM, Eckert RL. 2003. S100A7 (psoriasin) interacts with epidermal fatty acid binding protein and localizes in focal adhesion-like structures in cultured keratinocytes. J Invest Dermatol 121(1):132-141.
217. Rustandi RR, Baldisseri DM, Inman KG, Nizner P, Hamilton SM, Landar A, Zimmer DB, Weber DJ. 2002. Three-dimensional solution structure of the calcium-signaling protein apo-S100A1 as determined by NMR. Biochemistry 41(3):788-796.
218. Rustandi RR, Baldisseri DM, Weber DJ. 2000. Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat Struct Biol 7(7):570-574.
219. Sakaguchi M, Miyazaki M, Sonegawa H, Kashiwagi M, Ohba M, Kuroki T, Namba M, Huh NH. 2004. PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J Cell Biol 164(7):979-984.
220. Sakaguchi M, Miyazaki M, Takaishi M, Sakaguchi Y, Makino E, Kataoka N, Yamada H, Namba M, Huh NH. 2003. S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J Cell Biol 163(4):825-835.
221. Sakaguchi M, Sonegawa H, Nukui T, Sakaguchi Y, Miyazaki M, Namba M, Huh NH. 2005. Bifurcated converging pathways for high Ca 2+ - and TGFbeta-induced inhibition of growth of normal human keratinocytes. Proc Natl Acad SciUSA102(39):13921-13926.
222. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. 2006. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 396(2):201-214.
223. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418(6894):191-195.
224. Schafer BW, Fritschy JM, Murmann P, Troxler H, Durussel I, Heizmann CW, Cox JA. 2000. Brain S100A5 is a novel calcium-, zinc-, and copper ion-binding protein of the EF-hand superfamily. J Biol Chem 275(39):30623-30630.
225. Schafer BW, Wicki R, Engelkamp D, Mattei MG, Heizmann CW. 1995. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 25(3):638-643.
226. Schmidt AM, Yan SD, Yan SF, Stern DM. 2001. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108(7):949-955.
227. Semov A, Moreno MJ, Onichtchenko A, Abulrob A, Ball M, Ekiel I, Pietrzynski G, Stanimirovic D, Alakhov V. 2005. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 280(21):20833-20841.
228. Shao X, Li C, Fernandez I, Zhang X, Sudhof TC, Rizo J. 1997. Synaptotagmin-syntaxin interaction: the C2 domain as a Ca 2+ -dependent electrostatic switch. Neuron 18(1):133-142.
229. Sharp T. 2006. Neuroscience. A new molecule to brighten the mood. Science 311(5757):45-46.
230. Shiraishi N, Nishikimi M. 1998. Suppression of copper-induced cellular damage by copper sequestration with S100b protein. Arch Biochem Biophys 357(2):225-230.
231. Shirasawa M, Fujiwara N, Hirabayashi S, Ohno H, Iida J, Makita K, Hata Y. 2004. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 9(2):165-174.
232. Shishibori T, Oyama Y, Matsushita O, Yamashita K, Furuichi H, Okabe A, Maeta H, Hata Y, Kobayashi R. 1999. Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family. Biochem J 338 (Pt 3):583-589.
233. Sivaraja V, Kumar TK, Prudovsky I, Yu C. 2005. Three-dimensional solution structure of a unique S100 protein. Biochem Biophys Res Commun 335(4):1140-1148.
234. Sorci G, Bianchi R, Giambanco I, Rambotti MG, Donato R. 1999. Replicating myoblasts and fused myotubes express the calcium-regulated proteins S100A1 and S100B. Cell Calcium 25(2):93-106.
235. Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJ. 2001. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 21(19):7576-7586.
236. Srikrishna G, Panneerselvam K, Westphal V, Abraham V, Varki A, Freeze HH. 2001. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol 166(7):4678-4688.
237. Stary M, Schneider M, Sheikh SP, Weitzer G. 2006. Parietal endoderm secreted S100A4 promotes early cardiomyogenesis in embryoid bodies. Biochem Biophys Res Commun 343(2):555-563.
238. Stein U, Walther W, Crooks H, Waldman T, Harris ED, Arlt F, Mertins SD, Heizmann CW, Allard D, Birchmeier W, Schlag PM, Shoemaker RH. 2006. The metastasis associated gene S100A4 metastasin is a target of the B-catenin/TCF-pathway. Gastroenterology, in press.
239. Stitt AW, He C, Vlassara H. 1999. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. Biochem Biophys Res Commun 256(3):549-556.
240. Stulik J, Osterreicher J, Koupilova K, Knizek J, Bures J, Jandik P, Langr F, Dedic K, Schafer BW, Heizmann CW. 2000. Differential expression of the Ca 2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa. Eur J Cancer 36(8):1050-1059.
241. Sturchler E, Cox JA, I. Durussel, M. Weibel, C.W. Heizmann. 2006. S100A16, a novel calcium-binding protein of the EF-hand superfamily. J Biol Chem, in press.
242. Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, Greengard P. 2006. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311(5757):77-80.
243. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405(6784):354-360.
244. Takizawa T, Arai S, Kizawa K, Uchiwa H, Sasaki I, Inoue T. 1999. Ultrastructural localization of S100A3, a cysteine-rich, calcium binding protein, in human scalp hair shafts revealed by rapid-freezing immunocytochemistry. J Histochem Cytochem 47(4):525-532.
245. Tarabykina S, Kriajevska M, Scott DJ, Hill TJ, Lafitte D, Derrick PJ, Dodson GG, Lukanidin E, Bronstein I. 2000. Heterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid system. FEBS Lett 475(3):187-191.
246. Teratani T, Watanabe T, Yamahara K, Kumagai H, Ishikawa A, Arai K, Nozawa R. 2002. Restricted expression of calcium-binding protein S100A5 in human kidney. Biochem Biophys Res Commun 291(3):623-627.
247. Tomas A, Moss SE. 2003. Calcium- and cell cycle-dependent association of annexin 11 with the nuclear envelope. J Biol Chem 278(22):20210-20216.
248. Treves S, Scutari E, Robert M, Groh S, Ottolia M, Prestipino G, Ronjat M, Zorzato F. 1997. Interaction of S100A1 with the Ca 2+ release channel (ryanodine receptor) of skeletal muscle. Biochemistry 36(38):11496-11503.
249. Tsoporis JN, Marks A, Zimmer DB, McMahon C, Parker TG. 2003. The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart. Mol Cell Biochem 242(1-2):27-33.
250. Vallely KM, Rustandi RR, Ellis KC, Varlamova O, Bresnick AR, Weber DJ. 2002. Solution structure of human Mts1 (S100A4) as determined by NMR spectroscopy. Biochemistry 41(42):12670-12680.
251. van de Graaf SF, Hoenderop JG, Gkika D, Lamers D, Prenen J, Rescher U, Gerke V, Staub O, Nilius B, Bindels RJ. 2003. Functional expression of the epithelial Ca(2+) channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex. Embo J 22(7):1478-1487.
252. van der Eerden BC, Hoenderop JG, de Vries TJ, Schoenmaker T, Buurman CJ, Uitterlinden AG, Pols HA, Bindels RJ, van Leeuwen JP. 2005. The epithelial Ca 2+ channel TRPV5 is essential for proper osteoclastic bone resorption. Proc Natl Acad SciUSA102(48):17507-17512.
253. Van Eldik LJ, Wainwright MS. 2003. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 21(3-4):97-108.
254. Van Eldik LJ, Zimmer DB. 1987. Secretion of S-100 from rat C6 glioma cells. Brain Res 436(2):367-370.
255. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA. 2003. Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 171(5): 2602-2609.
256. Vissing H, Aagaard L, Tommerup N, Boel E. 1994. Localization of the human gene for advanced glycosylation end product-specific receptor (AGER) to chromosome 6p21.3. Genomics 24(3): 606-608.
257. Vives V, Alonso G, Solal AC, Joubert D, Legraverend C. 2003. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice. J Comp Neurol 457(4):404-419.
258. Vogel T, Leukert N, Barczyk, K. Strupat K, Roth J. Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations. Biochim. Biophys. Acta - Molecular Cell Research; 2006, in press.
259. Volkers M, Loughrey CM, Macquaide N, Remppis A, de George B, Wegner FV, Friedrich O, Fink RH, Koch WJ, Smith GL, Most P. 2006. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes. Cell Calcium.
260. Wang G, Platt-Higgins A, Carroll J, de Silva Rudland S, Winstanley J, Barraclough R, Rudland PS. 2006. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 66(2):1199-1207.
261. Wang G, Rudland PS, White MR, Barraclough R. 2000a. Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1. J Biol Chem 275(15):11141-11146.
262. Wang G, Zhang S, Fernig DG, Martin-Fernandez M, Rudland PS, Barraclough R. 2005. Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene 24(8): 1445-1454.
263. Wang G, Zhang S, Fernig DG, Spiller D, Martin-Fernandez M, Zhang H, Ding Y, Rao Z, Rudland PS, Barraclough R. 2004. Heterodimeric interaction and interfaces of S100A1 and S100P. Biochem J 382(Pt 1):375-383.
264. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB. 2000b. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 275(8):5626-5632.
265. Webb M, Emberley ED, Lizardo M, Alowami S, Qing G, Alfia'ar A, Snell-Curtis LJ, Niu Y, Civetta A, Myal Y, Shiu R, Murphy LC, Watson PH. 2005. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer 5:17.
266. Wicki R, Franz C, Scholl FA, Heizmann CW, Schafer BW. 1997. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 22(4):243-254.
267. Wicki R, Marenholz I, Mischke D, Schafer BW, Heizmann CW. 1996a. Characterization of the human S100A12 (calgranulin C, p6, CAAF1, CGRP) gene, a new member of the S100 gene cluster on chromosome 1q21. Cell Calcium 20(6):459-464.
268. Wicki R, Schafer BW, Erne P, Heizmann CW. 1996b. Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family. Biochem Biophys Res Commun 227(2):594-599.
269. Wilder PT, Baldisseri DM, Udan R, Vallely KM, Weber DJ. 2003. Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis. Biochemistry 42(46):13410-13421.
270. Wilder PT, Lin J, Bair CL, Charpentier TH, Yang D, Liriano M, Varney KM, Lee A, Oppenheim AB, Adhya S, Carrier F, Weber DJ. Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B. Biochim Biophys Acta - Molecular Cell Research; 2006, in press.
271. Wilder PT, Rustandi RR, Drohat AC, Weber DJ. 1998. S100B (betabeta) inhibits the protein kinase C-dependent phosphorylation of a peptide derived from p53 in a Ca 2+ -dependent manner. Protein Sci 7(3):794-798.
272. Winocur G, Roder J, Lobaugh N. 2001. Learning and memory in S100-beta transgenic mice: an analysis of impaired and preserved function. Neurobiol Learn Mem 75(2):230-243.
273. Wolf R, Voscopoulos CJ, FitzGerald PC, Goldsmith P, Cataisson C, Gunsior M, Walz M, Ruzicka T, Yuspa SH. 2006. The mouse S100A15 ortholog parallels genomic organization, structure, gene expression, and protein-processing pattern of the human S100A7/A15 subfamily during epidermal maturation. J Invest Dermatol 126(7):1600-1608.
274. Wright NT, Varney KM, Ellis KC, Markowitz J, Gitti RK, Zimmer DB, Weber DJ. 2005. The threedimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy. J Mol Biol 353(2):410-426.
275. Xiong Z, O'Hanlon D, Becker LE, Roder J, MacDonald JF, Marks A. 2000. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp Cell Res 257(2): 281-289.
276. Yamada A, Irie K, Hirota T, Ooshio T, Fukuhara A, Takai Y. 2005. Involvement of the annexin IIS100A10 complex in the formation of E-cadherin-based adherens junctions in Madin-Darby canine kidney cells. J Biol Chem 280(7):6016-6027.
277. Yamasaki R, Berri M, Wu Y, Trombitas K, McNabb M, Kellermayer MS, Witt C, Labeit D, Labeit S, Greaser M, Granzier H. 2001. Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1. Biophys J 81(4):2297-2313.
278. Yamashita N, Ilg EC, Schafer BW, Heizmann CW, Kosaka T. 1999. Distribution of a specific calciumbinding protein of the S100 protein family, S100A6 (calcyclin), in subpopulations of neurons and glial cells of the adult rat nervous system. J Comp Neurol 404(2):235-257.
279. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382(6593):685-691.
280. Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, Yu J, Soto C, Schmidt AM, Stern D, Kindy M. 2000. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med 6(6):643-651.
281. Ye F, Foell D, Hirono KI, Vogl T, Rui C, Yu X, Watanabe S, Watanabe K, Uese K, Hashimoto I, Roth J, Ichida F, Miyawaki T. 2004. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. Am J Cardiol 94(6):840-844.
282. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, MakitaZ, Takasawa S, Okamoto H, Watanabe T, Yamamoto H. 2003. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370(Pt 3):1097-1109.
283. Yui S, Nakatani Y, Hunter MJ, Chazin WJ, Yamazaki M. 2002. Implication of extracellular zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from target cells in its apoptosis-inducing activity. Mediators Inflamm 11(3):165-172.
284. Zhang H, Wang G, Ding Y, Wang Z, Barraclough R, Rudland PS, Fernig DG, Rao Z. 2003. The crystal structure at 2A resolution of the Ca 2+ -binding protein S100P. J Mol Biol 325(4):785-794.
285. Zhang H, Wang Z, Ding Y, Wang G, Wang X, Bartlam M, Tang H, Liu Y, Jiang F, Barraclough R, Rudland PS, Rao Z. 2002a. Crystallization and preliminary crystallographic analysis of a metastasisinducing protein, human S100A4. Acta Crystallogr D Biol Crystallogr 58(Pt 1):127-129.
286. Zhang T, Woods TL, Elder JT. 2002b. Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized, and malignant human keratinocytes. J Invest Dermatol 119(5):1196-1201.
287. Zhukova L, Zhukov I, Bal W, Wyslouch-Cieszynska A. 2004. Redox modifications of the C-terminal cysteine residue cause structural changes in S100A1 and S100B proteins. Biochim Biophys Acta 1742(1-3):191-201.
288. Zimmer DB. 1991. Examination of the calcium-modulated protein S100 alpha and its target proteins in adult and developing skeletal muscle. Cell Motil Cytoskeleton 20(4):325-337.
289. Zimmer DB, Chaplin J, Baldwin A, Rast M. 2005. S100-mediated signal transduction in the nervous system and neurological diseases. Cell Mol Biol (Noisy-le-grand) 51(2):201-214.
290. Zimmer DB, Cornwall EH, Landar A, Song W. 1995. The S100 protein family: history, function, and expression. Brain Res Bull 37(4):417-429.
291. Zimmer DB, Cornwall EH, Reynolds PD, Donald CM. 1998. S100A1 regulates neurite organization, tubulin levels, and proliferation in PC12 cells. J Biol Chem 273(8):4705-4711.
292. Zimmer DB, Landar A. 1995. Analysis of S100A1 expression during skeletal muscle and neuronal cell differentiation. J Neurochem 64(6):2727-2736.
293. Zimmer DB, Van Eldik LJ. 1989. Analysis of the calcium-modulated proteins, S100 and calmodulin, and their target proteins during C6 glioma cell differentiation. J Cell Biol 108(1):141-151.
294. Zimmer DB, Wright Sadosky P, Weber DJ. 2003. Molecular mechanisms of S100-target protein interactions. Microsc Res Tech 60(6):552-559.